Clinical Trial Update: DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating early dexamethasone administration in hospitalized COVID-19 pneumonia patients. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Viral
• Respiratory Distress Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Hospital Universitario Infanta Leonor | Conditions: COVID-19, Acute Respiratory Distress Syndrome | Phase 3 | Status: UNKNOWN